Management of Refractory Rhinitis with Montelukast and Fexofenadine

Expected Timeline and Efficacy

Montelukast begins working within 1-2 hours after administration, with clinical benefits evident by day 2, though maximum effectiveness may take 2-4 weeks to achieve 1
Assess response after 4-6 weeks of combination therapy; if clear benefits are not observed by this time, consider alternative therapies or diagnoses 1

Fexofenadine (like other antihistamines) is less effective for nasal congestion than for other nasal symptoms such as sneezing, itching, and rhinorrhea 2
Antihistamines are generally less effective than intranasal corticosteroids for overall allergic rhinitis control, particularly in patients with severe symptoms or significant nasal congestion 2

If the combination of montelukast and fexofenadine does not provide adequate relief after 4-6 weeks, intranasal corticosteroids should be considered as they are superior first-line agents for moderate-to-severe rhinitis 2

Montelukast has a safety profile similar to placebo in adults and children, with approval down to 6 months of age, and is non-sedating, dosed once daily, and can be used long-term without concern for tachyphylaxis 1
Various neuropsychiatric events have been reported as adverse events of montelukast, though the evidence of association is conflicting 3

Do not discontinue treatment prematurely if full benefits are not immediately apparent, as some therapeutic effects may take several weeks to fully develop 1
Do not use montelukast for acute symptom relief; it is a controller medication requiring daily use for optimal effect 1
If nonallergic rhinitis is suspected (vasomotor rhinitis or NARES), antihistamines including fexofenadine are generally ineffective, and intranasal corticosteroids are more appropriate 2
If nasal congestion remains the predominant uncontrolled symptom despite combination therapy, strongly consider switching to or adding intranasal corticosteroids rather than continuing ineffective oral therapy 2